Dhampur Bio Organics Limited has informed the Exchange regarding Appointment of Grant Thorton Bharat LLP as Internal Auditor of the company for FY 2025-26 w.e.f. July 28, 2025.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics reported its Q1 FY26 (quarter ended June 30, 2025) results alongside announcing the appointment of Grant Thornton Bharat LLP as its new Internal Auditor for FY 2025-26, effective July 28, 2025. Standalone revenue from operations grew to ₹821.19 crore, up about 28.7% year-on-year from ₹637.84 crore. Despite the strong revenue growth, the company slipped into a loss, posting a standalone loss after tax of ₹19.37 crore versus a profit of ₹1.11 crore in Q1 FY25, with EPS at ₹(2.92). The Sugar segment turned to a loss of ₹4.76 crore, while Country Liquor (₹4.33 crore) and Bio Fuels & Spirits (₹0.64 crore) remained profitable. On a consolidated basis, revenue was ₹783.68 crore with a loss after tax of ₹22.00 crore. The company noted that sugar is a seasonal industry, so quarterly performance may not reflect full-year results.
The sharp swing from profit to loss despite healthy revenue growth is a concern for short-term sentiment, though the company flags this as typical seasonal volatility in the sugar business. Replacing the internal auditor with a top-tier firm like Grant Thornton Bharat is a routine governance update and unlikely to move the stock materially on its own.